[HTML] mdpi.com

[HTML][HTML] Development of dementia in type 2 diabetes patients: mechanisms of insulin resistance and antidiabetic drug development

DD Singh, AA Shati, MY Alfaifi, SEI Elbehairi, I Han… - Cells, 2022 - mdpi.com
Dementia is reported to be common in those with type 2 diabetes mellitus. Type 2 diabetes
contributes to common molecular mechanisms and an underlying pathology with dementia …
被引用次数：13 相关文章

Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development.

DD Singh, AA Shati, MY Alfaifi, SEI Elbehairi, I Han… - Cells, 2022 - go.gale.com
Dementia is reported to be common in those with type 2 diabetes mellitus. Type 2 diabetes
contributes to common molecular mechanisms and an underlying pathology with dementia …

Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development

DD Singh, AA Shati, MY Alfaifi, SEI Elbehairi, I Han… - Cells, 2022 - pubmed.ncbi.nlm.nih.gov
Dementia is reported to be common in those with type 2 diabetes mellitus. Type 2 diabetes
contributes to common molecular mechanisms and an underlying pathology with dementia …

Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development

DD Singh, AA Shati, MY Alfaifi, SEI Elbehairi, I Han… - 2022 - agris.fao.org
Dementia is reported to be common in those with type 2 diabetes mellitus. Type 2 diabetes
contributes to common molecular mechanisms and an underlying pathology with dementia …

Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development

DD Singh, AA Shati, MY Alfaifi, SEI Elbehairi, I Han… - Cells, 2022 - search.proquest.com
Dementia is reported to be common in those with type 2 diabetes mellitus. Type 2 diabetes
contributes to common molecular mechanisms and an underlying pathology with dementia …
[PDF] academia.edu

[PDF][PDF] Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development. Cells 2022, 11, 3767

DD Singh, AA Shati, MY Alfaifi, SEI Elbehairi, I Han… - 2022 - academia.edu
Dementia is reported to be common in those with type 2 diabetes mellitus. Type 2 diabetes
contributes to common molecular mechanisms and an underlying pathology with dementia …
[HTML] nih.gov

[HTML][HTML] Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development

DD Singh, AA Shati, MY Alfaifi, SEI Elbehairi, I Han… - Cells, 2022 - ncbi.nlm.nih.gov
Dementia is reported to be common in those with type 2 diabetes mellitus. Type 2 diabetes
contributes to common molecular mechanisms and an underlying pathology with dementia …
[PDF] semanticscholar.org

[PDF][PDF] Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development. Cells 2022, 11, 3767

DD Singh, AA Shati, MY Alfaifi, SEI Elbehairi, I Han… - 2022 - pdfs.semanticscholar.org
Dementia is reported to be common in those with type 2 diabetes mellitus. Type 2 diabetes
contributes to common molecular mechanisms and an underlying pathology with dementia …

Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development.

DD Singh, AA Shati, MY Alfaifi, SEI Elbehairi, I Han… - Cells, 2022 - europepmc.org
Dementia is reported to be common in those with type 2 diabetes mellitus. Type 2 diabetes
contributes to common molecular mechanisms and an underlying pathology with dementia …

Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development

DD Singh, AA Shati, MY Alfaifi, SEI Elbehairi, I Han… - 2022 - scholarworks.bwise.kr
Dementia is reported to be common in those with type 2 diabetes mellitus. Type 2 diabetes
contributes to common molecular mechanisms and an underlying pathology with dementia …